Skip to main content
. 2021 Jul 4;24(1):76–83. doi: 10.1007/s12094-021-02671-0

Fig. 1.

Fig. 1

a Cumulative overall survival (OS) curves of all patients with pancreatic cancer; b OS curves of patients undergoing surgery alone (S) or surgery combined with radiotherapy (S + R). The log-rank test showed that the OS was significantly different between the two groups (p < 0.0001). S: surgery, S + R: surgery plus radiotherapy; c OS curves of patients undergoing surgery alone (S) or surgery combined with radiotherapy (S + R) after propensity score matching (PSM). The log-rank test showed that the OS was significantly different between the two groups (p < 0.0001). S: surgery, S + R: surgery plus radiotherapy